Evaluation of Pancreatic Malign Tumours with Mangafodipir Trisodium
dc.authorwosid | Tosun, Alptekin/AAA-1350-2021 | |
dc.contributor.author | Argimak, Yasin | |
dc.contributor.author | Temizoz, Osman | |
dc.contributor.author | Tosun, Alptekin | |
dc.contributor.author | Cakir, Bilge | |
dc.date.accessioned | 2024-06-12T11:08:08Z | |
dc.date.available | 2024-06-12T11:08:08Z | |
dc.date.issued | 2009 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Objectives: Our study aimed to assess the diagnostic capabilities of mangafodipir trisodium (Mn-DPDP)-enhanced magnetic resonance imaging for the evaluation of pancreatic malign mass. Patients and Methods: Magnetic resonance images of 17 patients (7 females, 10 males; mean age 63.2 +/- 12 years; range 36 to 80 years) suspected of pancreatic tumor by abdominal ultrasonography and computed tomography findings, were examined in terms of signal to noise (S/N) and contrast to noise (C/N) ratios before and after administration of Mn-DPDP using T1 A SE, Fat Sat T1 A SE and GRE T1 A sequences. Results: Before and after administration of Mn-DPDP, the increase in S/N ratios of normal pancreatic parenchyma were found as 22.81%, 32.88% and 20% in T1 A SE, Fat Sat T1 A SE and GRE T1 A sequences, respectively. The increase in C/N ratios obtained from signal intensity values of normal pancreatic tissue and tumor were found as 58.69%,125.41% and 62.06% in T1 A SE, Fat Sat T1 A SE and GRE T1 A sequences, respectively. Furthermore, in all sequences, before and after contrast medium administration, the increase of C/N ratios were found statistically significant (paired Student's t test, P<0.0001). Conclusion: The differences of C/N ratio using Mn-DPDP as a contrast agent may contribute to the diagnosis of pancreatic malign masses. | en_US |
dc.identifier.endpage | 58 | en_US |
dc.identifier.issn | 1301-3149 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-70349094908 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 53 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22297 | |
dc.identifier.volume | 26 | en_US |
dc.identifier.wos | WOS:000265174300009 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | tr | en_US |
dc.publisher | Aves Yayincilik, Ibrahim Kara | en_US |
dc.relation.ispartof | Trakya Universitesi Tip Fakultesi Dergisi | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Mangafodipir Trisodium (Mn-DPDP) | en_US |
dc.subject | Contrast-To-Noise Ratio | en_US |
dc.subject | Magnetic Resonance Imaging | en_US |
dc.subject | Pancreas | en_US |
dc.subject | Tumor | en_US |
dc.subject | Helical Ct | en_US |
dc.subject | Mn-Dpdp | en_US |
dc.subject | Adenocarcinoma | en_US |
dc.subject | Enhancement | en_US |
dc.subject | Diagnosis | en_US |
dc.subject | Disease | en_US |
dc.title | Evaluation of Pancreatic Malign Tumours with Mangafodipir Trisodium | en_US |
dc.type | Article | en_US |